Variables affecting in vivo performance of high-capacity adenovirus vectors

Journal of Virology

Volumn 76, Issue 4, 2002, Pages 1600-1609

  Schiedner, Gudrun ^a   Hertel, Sabine ^a   Johnston, Marion ^a   Biermann, Volker ^a   Dries, Volker ^a   Kochanek, Stefan ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA 1 ANTITRYPSIN; PHOSPHOGLYCERATE KINASE;

ANTIBODY RESPONSE; ARTICLE; CYTOMEGALOVIRUS; GENE CASSETTE; GENE CONSTRUCT; GENE EXPRESSION; GENE TRANSFER; NONHUMAN; PRIORITY JOURNAL;

ADENOVIRUSES, HUMAN; ALPHA 1-ANTITRYPSIN; ANIMALS; ANTIBODIES; CELL LINE; DNA, COMPLEMENTARY; DNA, VIRAL; GENE EXPRESSION REGULATION; GENETIC VECTORS; GENOME, VIRAL; HUMANS; LIVER; MICE; MICE, INBRED C57BL; PROMOTER REGIONS (GENETICS); TRANSDUCTION, GENETIC; TRANSGENES;

EID: 0036148167     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.4.1600-1609.2002     Document Type: Article

References (58)

1. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors
2. Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells
3. Complete sequence of a 38.4-kb human cosmid insert containing the polymorphic marker DXS455 from Xq28
4. Effect of the E4 region on the persistence of transgene expression from adenovirus vectors
5. E4ORF3 requirement for achieving long-term transgene expression from the cytomegalovirus promoter in adenovirus vectors
6. Effect of scaffold attachment region on transgene expression in retrovirus vectortransduced primary T cells and macrophages
7. Cellular promoters incorporated into the adenovirus genome: Effects of viral regulatory elements on transcription rates and cell specificity of albumin and β-globin promoter
8. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparison between immunocompetent and immunodeficient inbred strains
9. An efficient and flexible system for construction of adenovirus vectors with insertions and deletions in early region 1 and 3
10. Chromatin domains and prediction of MAR sequences
11. Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo
12. Adenovirus-mediated regulable target gene expression in vivo
13. Persistence in muscle of an adenoviral vector that lacks all viral genes
14. High-level tissue-specific expression of functional human factor VIII in mice
15. Circular Yac vectors containing small mammalian origin sequences can associate with nuclear matrix
16. Human beta interferon scaffold attachment region inhibits de novo methylation and confers long-term, copy number-dependent expression to retroviral vector
17. Sustained expression of human apolipoprotein A-I after adenoviral gene transfer in C57BL/6 mice: Role of apolipoprotein A-I promoter, apolipoprotein A-I intron and human apolipoprotein E enhancer
18. Automated DNA sequencing of the human HPRT locus
19. Recombinant adenovirus deleted for all viral genes for gene therapy of cystic fibrosis
20. Cohabitation of scaffold binding regions with upstream/enhancer elements of three developmentally regulated genes of D. melanogaster
21. Differential influence of E4 adenoviral genes on viral and cellular promoters
22. In vivo expression of full-length human dystrophin from adenoviral vectors deleted for all viral genes
23. The structure and expression of two defective adenovirus 2/simian virus 40 hybrids
24. Targeting cell-specific gene expression with an adenovirus vector containing the lacZ gene under the control of the CFTR promoter
25. Hepatic gene therapy: Persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo
26. High-capacity adenoviral vectors for gene transfer and somatic gene therapy
27. Encapsidated adenovirus minichromosome-mediated delivery of genes to the retina: Application to the rescue of photoreceptor degeneration
28. Role of intron 1 in expression of human factor IX gene
29. Recombinant adenovirus with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo
30. Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector
31. Adenovirus-mediated gene transfer: Influence of transgene, mouse strain and type of immune response on persistence of transgene expression
32. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: Comparison of E2a wild type and E2a deleted vectors
33. High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alantitrypsin with negligible toxicity
34. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene
35. Addition of human interferon beta scaffold attachment region to retroviral vector backbones increases the level of in vivo transgene expression among progeny of engrafted human hematopoietic stem cells
36. Heterologous introns can enhance expression of transgenes in mice
37. A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal
38. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging
39. Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors
40. Use of a liver-specific promoter reduced immune response to the transgene in adenoviral vectors
41. Adenovirus as an expression vector in muscle cells in vivo
42. Suicide gene expression induced in tumor cells transduced with recombinant adenoviral, retroviral and plasmid vectors containing the ERBB2 promoter
43. Optimization of the helper-dependent adenovirus system for production and potency in vivo
44. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
45. Efficient transformation of primary human amniocytes by E1 functions of Ad5: Generation of new cell lines for adenoviral vector production
46. Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice
47. Modulation of the specificity and activity of a cellular promoter in an adenoviral vector
48. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vivo and in vitro
49. Yeast ARS function and nuclear matrix association coincide in a short sequence from the human HPRT locus
50. Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with firstgeneration, but not with high-capacity, adenovirus vectors: Towards realistic long-term neurological gene therapy for chronic diseases
51. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors
52. MARs mission update
53. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy
54. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatoeytes in mice infected with E1-deleted recombinant adenoviruses
55. + CTLs in vivo
56. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adcnoviruses
57. Up-regulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell mediated elimination of recombinant adenovirus-infected hepatocytes in vivo
58. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo